INTERNATIONAL PATENT: MERZ PHARMA GMBH & CO. KGAA FILES APPLICATION FOR "SELF-CROSSLINKED HYDROGEL COMBINATION WITH BOTULINUM NEUROTOXIN"

GENEVA, May 18 -- MERZ PHARMA GMBH & CO. KGAA (Eckenheimer LandstraBe 10060318 Frankfurt am Main) filed a patent application (PCT/EP2025/081736) for "SELF-CROSSLINKED HYDROGEL COMBINATION WITH BOTULINUM NEUROTOXIN" on Nov 04, 2025. With publication no. WO/2026/099144, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELLE KUNZLER, Cleiton Jose (c/o Merz Aesthetics GmbHEckenheimer Landstrasse 10060318 Frankfurt am Main), DRABE, Colin (c/o Merz Aesthetics GmbHEckenheimer Landstrasse 10060318 Frankfurt am Main), VUKICEVIC, Ra...